Microbot Medical Inc.
Microbot Medical Inc. (MBOT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MBOT · as of Jun 9, 2026
Key Statistics
Explore Microbot Medical Inc. Data
mbot stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
The MBOT analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $4.00, representing +119.78% upside from the current price of $1.82.
Competitors & Peers
mbot competitorsMBOT
CLNN
CNTX
CRDL
DCGO
NSPRStock Performance
Full HistoryAbout Microbot Medical Inc.
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specif…
what is microbot medical inc. · mbot stock overview · microbot medical inc. company profile · who is microbot medical inc. ceo · mbot NASDAQ · microbot medical inc. headquarters · microbot medical inc. business segments
About Stock Overview & Key Data
Microbot Medical Inc. (MBOT) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Mar 25, 1992. As of the latest trading session, MBOT stock price is $1.82, with a market capitalization of $82.9M. The stock has returned -26.91% over the past 12 months and -9.00% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Microbot Medical Inc. stock is Buy, with an average 12-month price target of $4.00. In fiscal year 2025, Microbot Medical Inc. reported revenue of — and net income of -$13.1M. For detailed data — including Microbot Medical Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Microbot Medical Inc. (MBOT) stock price is $1.82. The stock is traded on NASDAQ under the ticker symbol MBOT. The 52-week range is $1.60 – $4.67.